• 60% HFD Induced DIO Rat Models

    Obesity is a chronic metabolic disorder characterized by excessive fat accumulation that poses significant risks to health. It arises from a complex interplay of genetic, environmental, behavioral, and hormonal factors, primarily driven by prolonged energy imbalance (caloric intake exceeding expenditure).


    Diet-induced obesity in SD rat


    The Diet-induced Obesity (DIO) rat model is a widely used preclinical tool for studying obesity, metabolic syndrome, and related comorbidities. By feeding rodents a high-fat or high-calorie diet (typically containing 45–60% fat), this model mimics human obesity development resulting from prolonged excessive energy intake.


    图片1.png

    Fig.1 Body weight and serum TC, TG, HDL-C and LDL-C of SD-DIO


    Body weight curve of SD-DIO is shown in Fig. 1A. The serum levels of TC, HDL-C, and LDL-C were significantly higher in SD-DIO rats compared to the control group, while the serum TG level is lower (Fig. 1B). Data were presented by mean ± SEM, N=10-60. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

     

     图片2.png

    Fig.2 OGTT, serum leptin and insulin of SD-DIO


    Following 8 weeks of HFD, SD-DIO rats showed impaired glucose tolerance (Fig. 2A). After 12 weeks of HFD, serum leptin and insulin levels of SD- DIO rat significantly increased compared to standard chow diet (Fig. 2B). Data were presented by mean ± SEM, N=10-20. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

     

    图片3.png

    Fig.3 Tissue weight and liver histological observation of SD-DIO


    The fat weight of SD-DIO increased significantly after 15 weeks of HFD (Fig.3A-B). Following 12 weeks of HFD, fat weight of SD-DIO increased significantly, while lean mass decreased (Fig.3C, data were collected via Dual-emission X-ray Absorptiometry). Hepatocytes in SD-DIO rats showed significant edema, steatosis, and lipid droplet deposition after 12 weeks of HFD (Fig.3D). Data were presented by mean ± SEM, N=6-20. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

     

    Pharmacodynamic evaluation of semaglutide (SEMA) on SD-DIO rat


    图片4.png

    Fig.4 Overview of pharmacodynamic evaluation of SEMA on SD-DIO rat

     

    图片5.png

    Fig.5 Body weight of SD-DIO decreased after SEMA treatment.


    Body weight of SD-DIO decreased after SEMA treatment. Data were presented by mean ± SEM, N=8. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

     

    图片6.png

    Fig.6 Food intake of SD-DIO decreased after SEMA treatment.


    Food intake of SD-DIO decreased after SEMA treatment. Data were presented by mean ± SEM, N=8. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

     

    图片7.png 

    Fig.7 Food intake of SD-DIO decreased after SEMA treatment.


    The fat weight of SD-DIO decreased after six-weeks of SEMA administration (Fig.7A). The fat percent of SD-DIO rat decreased after six-week SEMA administration. (Fig.7B, data collected via Dual-emission X-ray Absorptiometry). Data were presented by mean ± SEM, N=8. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

     

    图片8.png

    Fig.8 Liver TG, TC, LDL-C and histological observation of SD-DIO after SEMA treatment.


    TG, TC and LDL-C content in SD-DIO liver decreased significantly after six weeks of SEMA administration (Fig.8A). Oil red staining showed that the lipid droplet deposition in the liver of DIO rats decreased after six-week SEMA administration (Fig.8B). Data were presented by mean ± SEM, N=8. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

    TALK WITH OUR EXPERTS

    GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

    In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

    You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.